The customer observed multiple (b)(6) results while using the architect havab igg reagents.The following data was provided.(b)(6), multiple repeats (b)(6).The specimen was tested previously using a different architect reagent lot and was (b)(6).The specimen was (b)(6) when tested at another facility, however the method and specific value was not provided.No impact to patient management was reported.
|
Evaluation of the customer issue included a review of the complaint text, a search for similar complaints, device history review, labeling review, and specificity testing.Similar complaint review over a 12 month period identified no adverse trend for the customer issue.Device history review did not identify any issues that may have caused the customer issue.Labeling was reviewed and found to be adequate.The product was not available for return and no patient sample was returned, therefore clinical specificity testing of negative control replicates was performed using in-house retained kits stored at the recommended storage condition.Specificity testing met all specifications.Based on all available information and abbott diagnostics evaluation, no systemic issue was identified and no product deficiency was found.
|